Skip to main content
Premium Trial:

Request an Annual Quote

Jeremy Bridge-Cook

Rna Diagnostics has appointed Jeremy Bridge-Cook as its president and CEO. Prior to working at Rna Diagnostics, Bridge-Cook worked for 16 years in progressively senior roles in business development, research and development, and general management roles at Tm Bioscience, or TMB. During this time, he also served as a corporate officer and senior vice president of research and development at Luminex, acquired by TMB in 2007.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.